The prominent Greek pharmaceutical company began its activities in 1974. The company aims to provide high quality medicines at affordable prices. The company offers more than 150 different pharmaceutical products. It has an expanding presence in the domestic and international market. The company’s annual investments in research represent approximately 7% of the turnover. As a result, the company has established partnerships with leading companies in Europe and all over the world. Today the company has more than 500 employees.
The company is interested in establishing business collaboration with manufacturers of generic pharmaceutical products for the following medicines:
The Greek company would like to conduct a distribution services and license agreement with the producer of the aforementioned medicinal products, for the Greek market.